Lactulose (Duphalac Dry, Bifiteral Dry, Duphalac)
Lactulose
Abbott Laboratories S.A. (Pty) Ltd
Registration
- Applicant
- Abbott Laboratories S.A. (Pty) Ltd
- Certificate holder
- Abbott Laboratories SA (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Duphalac dry EACH 10,0 g POWDER CONTAINS LACTULOSE 10,0 g | 10gCrystalline powder / syrup | 28042728/11.5/0427Approved 27 May 1994 | Registered | Not determined | PIPIL |
| Bifiteral dry EACH 10,0 g SACHET CONTAINS LACTULOSE 10,0 g | Not listed | 37064237/11.5/0642 | Registered | Not determined | None |
| Duphalac EACH 5 ml SYRUP CONTAINS LACTULOSE 3,3 g | 10g/5mlSyrup | K0180K/11.5/180Approved 27 May 1994 | Registered | Not determined | PI |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-Dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Drag to rotate. Structure from PubChem CID 11333.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.